IL-23 promotes the development of castration-resistant prostate cancer

Juming Yan^{1

2}, Daniel J Cua³, Michele Wl Teng^{1

2}

Affiliations

¹ Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
² School of Medicine, University of Queensland, Brisbane, Australia.
³ Merck Research Laboratories, Palo Alto, CA, USA.

Comment

Juming Yan et al. Immunol Cell Biol. 2018 Oct.

. 2018 Oct;96(9):883-885.

doi: 10.1111/imcb.12195. Epub 2018 Sep 8.

Juming Yan^{1

2}, Daniel J Cua³, Michele Wl Teng^{1

2}

¹ Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
² School of Medicine, University of Queensland, Brisbane, Australia.
³ Merck Research Laboratories, Palo Alto, CA, USA.

No abstract available

Comment on

IL-23 secreted by myeloid cells drives castration-resistant prostate cancer.
Calcinotto A, Spataro C, Zagato E, Di Mitri D, Gil V, Crespo M, De Bernardis G, Losa M, Mirenda M, Pasquini E, Rinaldi A, Sumanasuriya S, Lambros MB, Neeb A, Lucianò R, Bravi CA, Nava-Rodrigues D, Dolling D, Prayer-Galetti T, Ferreira A, Briganti A, Esposito A, Barry S, Yuan W, Sharp A, de Bono J, Alimonti A. Calcinotto A, et al. Nature. 2018 Jul;559(7714):363-369. doi: 10.1038/s41586-018-0266-0. Epub 2018 Jun 27. Nature. 2018. PMID: 29950727 Free PMC article.